| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
BW
|
Feb 06, 2019
|
|||||
| GSE105936 |
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [PRO-seq]
|
|
2 | Gregory Donahue | Feb 06, 2019 | |||
| GSE105937 |
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence
|
|
150 |
|
Gregory Donahue | Feb 06, 2019 | ||
| GSE111821 |
Genome-wide RUNX1 binding landscape in AMLs with RUNX1 mutation
|
|
4 | Joost Martens | Feb 06, 2019 | |||
| GSE111917 |
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (ChIP-Seq)
|
|
8 | Joost Martens | Feb 06, 2019 | |||
| GSE111918 |
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq)
|
|
9 | Joost Martens | Feb 06, 2019 | |||
| GSE111919 |
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program
|
|
17 |
|
Joost Martens | Feb 06, 2019 | ||
| GSE126122 |
LncRNA HAND2-AS1 controls liver cancer stem cell functions and serves as a potential therapy target (ChiRP-Seq)
|
|
6 | Runsheng Chen | Feb 06, 2019 | |||
| GSE126123 |
LncRNA HAND2-AS1 controls liver cancer stem cell functions and serves as a potential therapy target
|
|
14 |
|
Runsheng Chen | Feb 06, 2019 |
